Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
Jian-Hong Zhong,1,* Cheng-Piao Luo,2,* Chun-Yan Zhang,2 Le-Qun Li1 1Hepatobiliary Surgery Department, 2Experimental Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People’s Republic of China *These authors contributed equally to this work Abstract: Immunothera...
Main Authors: | Zhong J, Luo C, Zhang C, Li L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-12-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/strengthening-the-case-that-elevated-levels-of-programmed-death-ligand-peer-reviewed-article-JHC |
Similar Items
-
Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
by: Gu X, et al.
Published: (2016-08-01) -
Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma
by: Ginji Omori, et al.
Published: (2021-09-01) -
Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
by: Yan X, et al.
Published: (2019-03-01) -
VEGF overexpression predicts poor survival in hepatocellular carcinoma
by: Choi Sae Byeol, et al.
Published: (2017-12-01) -
The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma: Associated with Improved Outcomes or Lack of Supportive Evidence?
by: Michelle Ju, et al.
Published: (2019-09-01)